Autoimmune Treatment Market Overview, Analysis And Demand By 2034


This market research is a valuable tool for leaders seeking to align their strategies with the realities and opportunities in the autoimmune treatment industry.

Autoimmune Treatment Market Analysis & Forecast: 2025-2029
The autoimmune treatment market size has grown rapidly in recent years. It will grow from $7.72 billion in 2024 to $8.63 billion in 2025 at a compound annual growth rate (CAGR) of 11.7%. The growth in the historic period can be attributed to increasing prevalence, advancements in immunology, genetic research insights, patient awareness and advocacy, regulatory support.

The autoimmune treatment market size is expected to see rapid growth in the next few years. It will grow to $14.54 billion in 2029 at a compound annual growth rate (CAGR) of 13.9%. The growth in the forecast period can be attributed to precision medicine approaches, emergence of small molecule therapies, targeting novel pathways, gene therapy innovations, increasing biopharmaceutical investments, biosimilar market growth. Major trends in the forecast period include advancements in biologics and targeted therapies, immunomodulatory therapies, focus on rare autoimmune diseases, telemedicine and remote monitoring, regulatory initiatives and drug approvals, integration of digital health tools.

Get your free sample today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7863&type=smp

What Are The Factors Driving The Autoimmune Treatment Market?
The increase in investments in research and development of drugs for autoimmune diseases are expected to propel the growth of the autoimmune treatment market going forward. Research and development are the actions businesses take to innovate and launch new goods and services. Research and development of drugs for autoimmune diseases allows for the development of more targeted, low-molecular-weight, orally active, and chemically characterized immune suppressive drugs with acceptable tolerability in the context of long-term autoimmune disease treatment. For instance, in January 2022, Eli Lilly and Company, a US-based pharmaceutical company, increased its R&D investment from $7 billion in 2021 to $7.19 billion in 2022, resulting in an increase in its R&D spend as a percentage of revenue from 24.8% to 25.19%. Therefore, the increasing investments in research and development of drugs drives the autoimmune treatment market growth.

What Segments Are Covered In The Autoimmune Treatment Market Report?
The autoimmune treatmentmarket covered in this report is segmented –

1) By Product: Consumables And Assay Kits; Instruments; Services
2) By Service Type: Consultation And Diagnosis; Therapy And monitoring; Drug development
3) By Disease: Rheumatoid Arthritis; Systemic Lupus Erythematosus; Sjögren’s Syndrome; Thyroiditis; Scleroderma; Other Diseases
4) By Drug Class: Anti-Inflammatory; Anti-Hyperglycemic; NSAIDs; Interferons; Other Drug Class

Subsegments:
1) By Consumables And Assay Kits: ELISA Kits; Reagents And Antibodies; Sample Collection Kits
2) By Instruments: Diagnostic Equipment; Imaging Systems
3) By Services: Testing And Diagnostics Services; Consultation And Support Services; Data Analysis And Interpretation Services

What Are The Main Trends, Positively Impacting The Growth Of Autoimmune Treatment Market?
Technological advancements are a key trend gaining popularity in the autoimmune treatment market. Major companies operating in the market are developing advanced technologies to sustain their position in the market. For instance, in June 2023, UCB, a Belgium-based pharmaceutical company, received approval from the U.S. Food and Drug Administration (FDA) for RYSTIGGO (rozanolixizumab-noli) in the treatment of generalized myasthenia gravis (gMG) in adults who test positive for anti-acetylcholine receptor (AchR) or anti-muscle-specific tyrosine kinase (MuSK) antibodies, with the approval being expedited under Priority Review. RYSTIGGO stands as the exclusive FDA-approved therapy for both anti-AchR and anti-MuSK antibody-positive gMG, encompassing the two most prevalent subtypes of this condition diagnosis of autoimmune illnesses, which might improve provider efficiency, increase the efficacy of treatment, and improve patient care.

Which Are The Major Players Operating In The Global Autoimmune Treatment Market?
Major companies operating in the autoimmune treatment market are Abbott Laboratories, Amgen Inc., Johnson & Johnson Services Inc., Eli Lilly and Company, Pfizer Inc., Hoffmann-La Roche AG, AstraZeneca PLC, Bristol-Myers Squibb Company, Autoimmune Inc., Siemens Healthcare Private Limited, Thermo Fisher Scientific Inc., Biogen Idec Inc., Bayer Schering Pharma AG, GSK PLC, Genentech Inc., AbbVie Inc., Celgene Corporation, Gilead Sciences Inc., Merck & Co. Inc., Novartis International AG, Sanofi SA, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., UCB SA, Alexion Pharmaceuticals Inc., Amarin Corporation PLC, AnaptysBio Inc., Apellis Pharmaceuticals Inc., Arena Pharmaceuticals Inc., Aurinia Pharmaceuticals Inc., BioCryst Pharmaceuticals Inc., Biohaven Pharmaceutical Holding Company Ltd., BioMarin Pharmaceutical Inc., bluebird bio Inc., Cabaletta Bio Inc., Catabasis Pharmaceuticals Inc., ChemoCentryx Inc., Coherus BioSciences Inc., Corbus Pharmaceuticals Holdings Inc., CSL Limited, Cumberland Pharmaceuticals Inc., CytoDyn Inc.

View the full autoimmune treatment market report here:
https://www.thebusinessresearchcompany.com/report/autoimmune-treatment-global-market-report

Autoimmune Treatment Market Regional Insights:
North America was the largest region in the autoimmune treatment market in 2024. The regions covered in the autoimmune treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company

https://thebusinessresearchcompany.com/

Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267

Email: info@tbrc.info


Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Comments

Post a Comment

Popular posts from this blog

Paperboard Packaging Market Analysis, Share And Growth By 2025 - 2034

Image
Drawing from trusted sources and expert analysis, this report helps businesses navigate the complex landscape of the paperboard packaging industry. Paperboard Packaging Market Analysis & Forecast: 2025-2029 The paperboard packaging market size has grown steadily in recent years. It will grow from $213.03 billion in 2024 to $221.76 billion in 2025 at a compound annual growth rate (CAGR) of 4.1%. The growth in the historic period can be attributed to sustainable packaging demand, shift from plastic to paperboard, brand preference for eco-friendly packaging, regulatory changes, cost-efficiency of paperboard. The paperboard packaging market size is expected to see strong growth in the next few years. It will grow to $296.77 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to rise in convenience packaging, product protection demands, health and safety concerns, customization and branding, cost-efficiency. Major tren...
Read more

Unattended Terminals Market Scope, Size And Growth 2025

Image
Unlock 30% off global market reports with code ONLINE30 – get insights on tariff changes, macro trends, and global economic shifts. What is the forecasted revenue size of the unattended terminals industry by 2029? The unattended terminals market size has grown rapidly in recent years. It will grow from $1.58 billion in 2024 to $1.76 billion in 2025 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to the expansion of e-commerce growth, increasing smartphone integration, rising demand for contactless payments, rise in data analytics, and growth in the healthcare industry. The unattended terminals market size is expected to see rapid growth in the next few years. It will grow to $2.69 billion in 2029 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to growth in the retail industry, rise in smart cities, rise in digital payments, growing shift towards consumer convenience, and acc...
Read more

Freight Transport Management Market Size, Scope And Growth 2025 To 2034

Image
Unlock 30% off global market reports with code ONLINE30 – get insights on tariff changes, macro trends, and global economic shifts. What is the projected value of the freight transport management market by 2029? The freight transport management market size has grown rapidly in recent years. It will grow from $27.28 billion in 2024 to $30.5 billion in 2025 at a compound annual growth rate (CAGR) of 11.8%. The growth in the historic period can be attributed to increased globalization, growing population, increase in demand for goods and services, increase in government policies aimed at promoting global trade, and rising freight transportation. The freight transport management market size is expected to see rapid growth in the next few years. It will grow to $46.99 billion in 2029 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to trade expansion, the rise of the e-commerce industry, the increasing complexity of supply chains, th...
Read more